Update in primary aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 10, 2009, Pages 3623-3630

  Stowasser, Michael ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMILORIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DROSPIRENONE PLUS ETHINYLESTRADIOL; EPLERENONE; GLUCOCORTICOID; HYDRALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; PRAZOSIN; RENIN; SPIRONOLACTONE; STEROID; VERAPAMIL;

ADRENAL HYPERPLASIA; ADRENALECTOMY; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; ESSENTIAL HYPERTENSION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GOLD STANDARD; GYNECOMASTIA; HEREDITY; HUMAN; HYPERKALEMIA; HYPERTENSION; LOW DRUG DOSE; MORBIDITY; MORTALITY; NONHUMAN; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SCREENING; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 70349898632     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1399     Document Type: Article

References (52)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
2. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ, Kathiresan S, O'Donnell CJ, Musone SL, Camargo AL, Drake JA, Levy D, Hirschhorn JN, Vasan RS 2007 Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 49:846-856 (Pubitemid 351664212)
3. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M 2005 Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 23:1477-1484 (Pubitemid 41104818)
4. Sukor N, Mulatero P, Gordon RD, So A, Duffy D, Bertello C, Kelemen L, Jeske Y, Veglio F, Stowasser M 2008 Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens 26:1577-1582
5. Weber KT, Brilla CG 1991 Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849-1865
6. Bernini G, Galetta F, Franzoni F, Bardini M, Taurino C, Bernardini M, Ghiadoni L, Bernini M, Santoro G, Salvetti A 2008 Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 26:2399-2405
7. Holaj R, Zelinka T, Wichterle D, Petrák O, Strauch B, Widimský J Jr 2007 Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension. J Hypertens 25:1451-1457 (Pubitemid 46918833)
8. Tsuchiya K, Yoshimoto T, Hirata Y 2009 Endothelial dysfunction is related to aldosterone excess and raised blood pressure. Endocr J 56:553-559
9. Tsioufis C, Tsiachris D, Dimitriadis K, Stougiannos P, Missovoulos P, Kakkavas A, Stefanadis C, Kallikazaros I 2008 Myocardial and aortic stiffening in the early course of primary aldosteronism. Clin Cardiol 31:431-436
10. Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH 2005 Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90:5070-5076 (Pubitemid 41262256)
11. Staermose S, Marwick TH, Gordon RD, Cowley D, Dowling A, Stowasser M 2009 Elevated serum interleukin 6 levels in normotensive individuals with familial hyperaldosteronism type 1. Hypertension 53:e31-e32
12. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238 (Pubitemid 44309817)
13. Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C 2009 Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 94:1191-1197
14. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
15. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M 2009 Cardio- and cerebrovascular comorbidites of hypo- and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab 94:1125-1130
16. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA 2008 Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168:80-85
17. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, Boscaro M 2007 Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25:177-186 (Pubitemid 44885680)
18. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P 2006 Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91:454-459 (Pubitemid 43236909)
19. Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, Veglio F, Mulatero P 2007 Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 20:855-861 (Pubitemid 47176347)
20. Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF 2009 Fasting plasma glucose and serum lipids in patients with primary aldosteronism.Acontrolled cross-sectional study. Hypertension 53:605-610
21. Strauch B, Petrák O, Zelinka T, Wichterle D, Holaj R, Kasalický M, Safarík L, Rosa J, Widimský Jr J 2008 Adrenalectomy improves arterial stiffness in primary aldosteronism. Am J Hypertens 21:1086-1092
22. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA 2007 Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50:911-918 (Pubitemid 350287534)
23. Delyani JA 2000 Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int 57:1408-1411 (Pubitemid 30207899)
24. Karagiannis A, Tziomalos K, Papageorgiou A, Kakafika AI, Pagourelias ED, Anagnostis P, Athyros VG, Mikhailidis DP 2008 Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother 9:509-515
25. Rutherford JC, Taylor WL, Stowasser M, Gordon RD 1998 Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production. World J Surg 22:1243-1245 (Pubitemid 28514344)
26. Harris DA, Au-Yong I, Basnyat PS, Sadler GP, Wheeler MH 2003 Review of surgical management of aldosterone secreting tumours of the adrenal cortex. Eur J Surg Oncol 29:467-474 (Pubitemid 36748592)
27. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G 2005 Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 71:864-869
28. Gilbert JW, Bell NH, Bartter FC 1963 Primary aldosteronism: diagnosis and surgical treatment. Ann Surg 158:195-204
29. George JM, Wright L, Bell NH, Bartter FC 1970 The syndrome of primary aldosteronism. Am J Med 48:343-356
30. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP 1979 Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med 90:386-395 (Pubitemid 9125723)
31. Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M 2009 Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab 94:2437-2445
32. Jansen PM, van den Meiracker AH, Jan Danser AH 2009 Aldosterone synthase inhibitors: pharmacological and clinical aspects. Curr Opin Investig Drugs 10:319-326
33. Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902 (Pubitemid 35434913)
34. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618
35. Oelkers WK 1996 Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166-171 (Pubitemid 26146736)
36. Stowasser M, Gordon RD 2004 The aldosterone-renin ratio for screening for primary aldosteronism. Endocrinologist 14:267-276 (Pubitemid 39232121)
37. Pizzolo F, Pavan C, Corrocher R, Olivieri O 2007 Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. Am J Hypertens 20:1334-1337 (Pubitemid 350151688)
38. Fommei E, Ghione S, Ripoli A, Maffei S, Di Cecco P, Iervasi A, Turchi S 2009 The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women. J Hum Hypertens 23:130-135
39. Campbell DJ, Nussberger J, Stowasser M, Danser AH, Morganti A, Frandsen E, Ménard J 2009 Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 55:867-877
40. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F 2007 Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50: 424-431 (Pubitemid 47205795)
41. Mulatero P, Bertello C, Garrone C, Rossato D, Mengozzi G, Verhovez A, Fallo F, Veglio F 2007 Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension 50:e26-e27 (Pubitemid 47205812)
42. Stowasser M, Gordon RD 2003 Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17:591-605
43. Schwab 2nd CW, Vingan H, Fabrizio MD 2008 Usefulness of adrenal vein sampling in the evaluation of aldosteronism. J Endourol 22:1247-1250
44. Mengozzi G, Rossato D, Bertello C, Garrone C, Milan A, Pagni R, Veglio F, Mulatero P 2007 Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 53: 1968-1971 (Pubitemid 350036044)
45. Seccia TM, Miotto D, De Toni R, Pitter G, Mantero F, Pessina AC, Rossi GP 2009 Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension 53:761-766
46. Rossi GP, Seccia TM, Pessina AC 2008 Primary aldosteronism: part II: subtype differentiation and treatment. J Nephrol 21:455-462
47. Young WF, Stanson AW 2009 What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70:14-17
48. Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M 2006 Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. Clin Chem 52: 1749-1755 (Pubitemid 44330710)
49. Taylor PJ, Cooper DP, Gordon RD, Stowasser M 2009 Measurement of aldosterone in human plasma by semiautomated HPLCtandem mass spectrometry. Clin Chem 55:1155-1162
50. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA 2000 A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37:831-835 (Pubitemid 30843791)
51. Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B, Gordon RD, Duffy D, Stowasser M 2008 Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin Exp Pharmacol Physiol 35:380-385
52. Sukor N, Jeske Y, Dowling A, So A, Kelemen L, Gordon R, Stowasser M 2009 Examination of chromosome 7p22 candidate genes RPA3, ZNF12 and GLCCI1 in familial hyperaldosteronism type II. J Hypertens 27:S448-S449